The OMER chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OMER chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The OMER stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View OMER Detailed Price Forecast - CNN Money||View OMER Detailed Summary - Google Finance|
|View OMER Detailed Summary - Yahoo! Finance||View OMER Stock Research & Analysis - Zacks.com|
|View OMER Trends & Analysis - Trade-Ideas||View OMER Major Holders - Barrons|
|View OMER Call Transcripts - NASDAQ||View OMER Breaking News & Analysis - Seeking Alpha|
|View OMER Annual Report - CompanySpotlight.com||View OMER OTC Short Report - OTCShortReport.com|
|View OMER Fundamentals - TradeKing||View OMER SEC Filings - Bar Chart|
|View Historical Prices for OMER - The WSJ||View Performance/Total Return for OMER - Morningstar|
|View the Analyst Estimates for OMER - MarketWatch||View the Earnings History for OMER - CNBC|
|View the OMER Earnings - StockMarketWatch||View OMER Buy or Sell Recommendations - MacroAxis|
|View the OMER Bullish Patterns - American Bulls||View OMER Short Pain Metrics - ShortPainBot.com|
|View OMER Stock Mentions - StockTwits||View OMER Stock Mentions - PennyStockTweets|
|View OMER Stock Mentions - Twitter||View OMER Investment Forum News - Investor Hub|
|View OMER Stock Mentions - Yahoo! Message Board||View OMER Stock Mentions - Seeking Alpha|
|View Insider Transactions for OMER - SECform4.com||View Insider Transactions for OMER - Insider Cow|
|View OMER Major Holdings Summary - CNBC||View Insider Disclosure for OMER - OTC Markets|
|View Insider Transactions for OMER - Yahoo! Finance||View Institutional Holdings for OMER - NASDAQ|
|View OMER Stock Insight & Charts - FinViz.com||View OMER Investment Charts - StockCharts.com|
|View OMER Stock Overview & Charts - BarChart||View OMER User Generated Charts - Trading View|
Omeros Announces Research Collaboration with University of Cambridge
Posted on Tuesday December 11, 2018
Omeros Corporation (OMER) today announced that it has entered into a research collaboration with the University of Cambridge, establishing the Omeros Center at Cambridge for Complement and Inflammation Research (OC3IR). The OC3IR currently is focusing on research related to OMS721, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the effector enzyme of the complement system’s lectin pathway, and to OMS906, Omeros’ lead human monoclonal antibody targeting MASP-3, the key activator of the complement system’s alternative pathway.
Omeros Announces Clinical Strategy to Accelerate Pediatric Development of OMS721 for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)
Posted on Thursday December 06, 2018
– EMA Confirmed OMS721 Eligibility for European Centralized Marketing Authorization Application Review –
Omeros Announces Additions to Senior Management Team
Posted on Monday December 03, 2018
Omeros Corporation (OMER) today announced that it hired two new senior management team members – Daniel Kirby as vice president and head of commercial and Justin McCue, Ph.D. as vice president of chemistry, manufacturing and controls (CMC). OMIDRIA is the company’s marketed drug and the only product of its kind for cataract and lens replacement surgery.
Edited Transcript of OMER earnings conference call or presentation 9-Nov-18 1:30pm GMT
Posted on Monday December 03, 2018
Q3 2018 Omeros Corp Earnings Call